171 related articles for article (PubMed ID: 37928274)
1. Glutamine metabolism controls amphiregulin-facilitated chemoresistance to cisplatin in human chondrosarcoma.
Wu YY; Law YY; Huang YW; Tran NB; Lin CY; Lai CY; Huang YL; Tsai CH; Ko CY; Chou MC; Huang WC; Cheng FJ; Fong YC; Tang CH
Int J Biol Sci; 2023; 19(16):5174-5186. PubMed ID: 37928274
[TBL] [Abstract][Full Text] [Related]
2. Amphiregulin promotes cisplatin chemoresistance by upregulating ABCB1 expression in human chondrosarcoma.
Huang YW; Lin CY; Tsai HC; Fong YC; Han CK; Huang YL; Wu WT; Cheng SP; Chang HC; Liao KW; Wang SW; Tang CH
Aging (Albany NY); 2020 May; 12(10):9475-9488. PubMed ID: 32428872
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin enhances cell migration and resistance to doxorubicin in chondrosarcoma cells through the MAPK pathway.
Chen JC; Huang C; Lee IN; Wu YP; Tang CH
Mol Carcinog; 2018 Dec; 57(12):1816-1824. PubMed ID: 30230033
[TBL] [Abstract][Full Text] [Related]
4. Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
Wang C; Wu J; Wang Z; Yang Z; Li Z; Deng H; Li L; Peng X; Feng M
Biomaterials; 2018 Nov; 183():77-92. PubMed ID: 30149232
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin enhances VEGF-A production in human chondrosarcoma cells and promotes angiogenesis by inhibiting miR-206 via FAK/c-Src/PKCδ pathway.
Wang CQ; Huang YW; Wang SW; Huang YL; Tsai CH; Zhao YM; Huang BF; Xu GH; Fong YC; Tang CH
Cancer Lett; 2017 Jan; 385():261-270. PubMed ID: 27826039
[TBL] [Abstract][Full Text] [Related]
6. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
[TBL] [Abstract][Full Text] [Related]
7. ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells.
Luo Y; Li W; Ling Z; Hu Q; Fan Z; Cheng B; Tao X
Cancer Med; 2020 May; 9(10):3489-3499. PubMed ID: 32162845
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
Zhu Z; Wang CP; Zhang YF; Nie L
Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
[TBL] [Abstract][Full Text] [Related]
9. Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway.
Chen JC; Chen YJ; Lin CY; Fong YC; Hsu CJ; Tsai CH; Su JL; Tang CH
Oncotarget; 2015 May; 6(13):11434-46. PubMed ID: 25825984
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of EGFR-induced glucose metabolism sensitizes chondrosarcoma cells to cisplatin.
Song YD; Zhang KF; Liu D; Guo YQ; Wang DY; Cui MY; Li G; Sun YX; Shen JH; Li XG; Zhang L; Shi FJ
Tumour Biol; 2014 Jul; 35(7):7017-24. PubMed ID: 24748236
[TBL] [Abstract][Full Text] [Related]
11. Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells.
Wang W; Pan H; Ren F; Chen H; Ren P
Biosci Rep; 2022 Mar; 42(3):. PubMed ID: 35237783
[TBL] [Abstract][Full Text] [Related]
12. Overcoming cisplatin resistance of human lung cancer by sinomenine through targeting the miR-200a-3p-GLS axis.
Liu X; Chen L; Wang T
J Chemother; 2023 Jul; 35(4):357-366. PubMed ID: 36120905
[TBL] [Abstract][Full Text] [Related]
13. Amphiregulin Promotes Vascular Endothelial Growth Factor-C Expression and Lymphangiogenesis through STAT3 Activation in Human Chondrosarcoma Cells.
Huang YW; Tsai HC; Wang SW; Kuo SJ; Fong YC; Tang CH
Cell Physiol Biochem; 2019; 52(1):1-15. PubMed ID: 30790501
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition.
Liu Z; Peng Q; Li Y; Gao Y
BMB Rep; 2018 Sep; 51(9):474-479. PubMed ID: 30103844
[TBL] [Abstract][Full Text] [Related]
15. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer.
White MA; Lin C; Rajapakshe K; Dong J; Shi Y; Tsouko E; Mukhopadhyay R; Jasso D; Dawood W; Coarfa C; Frigo DE
Mol Cancer Res; 2017 Aug; 15(8):1017-1028. PubMed ID: 28507054
[TBL] [Abstract][Full Text] [Related]
16. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
[TBL] [Abstract][Full Text] [Related]
17. Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis.
Fan WH; Wang FC; Jin Z; Zhu L; Zhang JX
Curr Med Sci; 2022 Feb; 42(1):108-117. PubMed ID: 34958454
[TBL] [Abstract][Full Text] [Related]
18. A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.
Yoo HC; Park SJ; Nam M; Kang J; Kim K; Yeo JH; Kim JK; Heo Y; Lee HS; Lee MY; Lee CW; Kang JS; Kim YH; Lee J; Choi J; Hwang GS; Bang S; Han JM
Cell Metab; 2020 Feb; 31(2):267-283.e12. PubMed ID: 31866442
[TBL] [Abstract][Full Text] [Related]
19. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
[TBL] [Abstract][Full Text] [Related]
20. Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.
Cetindis M; Biegner T; Munz A; Teriete P; Reinert S; Grimm M
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):495-503. PubMed ID: 25663193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
